Results 41 to 50 of about 530,563 (260)

First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. [PDF]

, 2018
PURPOSE: To investigate the utility of 153Sm lexidronam (Quadramet) in the setting of men with prostate cancer status post radical prostatectomy who develop biochemical failure with no clinical evidence of osseous metastases.
Girvigian, Michael R., Hoffman-Censits, Jean, Ko, Eric C., Pugh, Stephanie L., Rosenthal, Seth A., Sandler, Howard M., Sartor, Oliver, Schallenkamp, John, Shaves, Mark E., Trabulsi, Edouard J., Valicenti, Richard K.   +10 more
core   +2 more sources

Nanotechnology in Radiation Oncology

Hematology/Oncology Clinics of North America, 2019
Nanotechnology has made remarkable contributions to clinical oncology. Nanotherapeutics and diagnostic tools have distinctive characteristics which allow them superior abilities to deliver therapeutics and imaging agents for radiation oncology. Compared to solid biopsies and imaging, the analysis of circulating tumor cells (CTCs) offers a more rapid ...
Andrew Z. Wang, Joseph M. Caster, C. Tilden Hagan, Bo Sun   +3 more
openaire   +3 more sources

Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization

Radiation Oncology, 2023
Background Setup reproducibility of the tissue in the proton beam path is critical in maintaining the planned clinical target volume (CTV) dose coverage and sparing the organs at risk (OAR).
Yixiu Kang, Martin Bues, Michele Y. Halyard, Lisa A. McGee, Tamara Z. Vern-Gross, William W. Wong, Sameer R. Keole, Carlos Vargas, Sarah E. James, Safia K. Ahmed, James P. Archuleta, Ana K. Ridgway, Pedro R. Lara, Mirek Fatyga   +13 more
doaj   +1 more source

Analyzing the Role of Research in the Radiation Oncology Match

Advances in Radiation Oncology, 2022
Purpose: Program directors consider scholarly output to be integral in matching applicants with radiation oncology residencies. However, applicants’ research productivity can be quantified in several ways, and the results can be misleading for both ...
Austin Huang, BSA, Jillian R. Gunther, MD, PhD, Lilie L. Lin, MD   +2 more
doaj   +1 more source

Stereotactic Radiosurgery Practice Patterns for Brain Metastases in the United States: A National Survey [PDF]

, 2018
Background: Stereotactic radiosurgery (SRS) has emerged as an important modality for the treatment of intracranial metastases. There are currently few established guidelines delineating indications for SRS use and fewer still regarding plan evaluation in
Bhamidipati, Deepak, Blomain, Erik S, Garg, Shivank, Guo, Jenny, Kalchman, Ingrid, Kim, MD, Hyun, McAna, John F., Shi, Wenyin   +7 more
core   +2 more sources

Increasing pediatric radiation oncology capacity in sub-saharan Africa using technology: a pilot of a pediatric radiation oncology virtual training course

BMC Medical Education
Background The shortage of skilled healthcare professionals in pediatric oncology and the limited access to training programs remain significant challenges in Nigeria and sub-Saharan Africa. The the Pediatric Radiation Oncology (Virtual) Course, ‘PedROC’
Adedayo O. Joseph, Adeseye M. Akinsete, Azeezat O. Ajose, Aishat T. Oladipo, Adeola Maliki, Korede Akindele, Michelle Mangongolo, Samuel Adeneye, Wilfred Ngwa   +8 more
doaj   +1 more source

Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma

BMC Cancer, 2018
Background To evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) in patients with small hepatocellular carcinoma(sHCC) who were ineligible for surgery or ablation therapies.
Tao Zhang, Jing Sun, Weiping He, Huan Li, Junjie Piao, Huijun Xu, Xuezhang Duan   +6 more
doaj   +1 more source

Image guidance in radiation therapy for better cure of cancer

Molecular Oncology, 2020
The key goal and main challenge of radiation therapy is the elimination of tumors without any concurring damages of the surrounding healthy tissues and organs.
Vincent Grégoire, Matthias Guckenberger, Karin Haustermans, Jan J. W. Lagendijk, Cynthia Ménard, Richard Pötter, Ben J. Slotman, Kari Tanderup, Daniela Thorwarth, Marcel vanHerk, Daniel Zips   +10 more
doaj   +1 more source

Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study

Advances in Radiation Oncology, 2021
Purpose: To examine the effectiveness and safety of single-isocenter multitarget stereotactic radiosurgery using a volume-adapted dosing strategy in patients with 4 to 10 brain metastases.
Grace J. Kim, MD, PhD, Evan D. Buckley, MS, James E. Herndon, PhD, Karen J. Allen, NP, Tyketra S. Dale, NP, Justus D. Adamson, PhD, Lam Lay, BA, William M. Giles, PhD, Anna E. Rodrigues, PhD, Zhiheng Wang, PhD, Chris R. Kelsey, MD, Jordan A. Torok, Jr, MD, Junzo P. Chino, MD, Peter E. Fecci, MD, PhD, John H. Sampson, MD, PhD, MBA, Carey K. Anders, MD, Scott R. Floyd, MD, PhD, Fang-Fang Yin, PhD, John P. Kirkpatrick, MD, PhD   +18 more
doaj   +1 more source

Interobserver Reliability in Describing Radiographic Lung Changes After Stereotactic Body Radiation Therapy [PDF]

, 2018
Purpose Radiographic lung changes after stereotactic body radiation therapy (SBRT) vary widely between patients. Standardized descriptions of acute (≤6 months after treatment) and late (\u3e6 months after treatment) benign lung changes have been proposed
Hugo, Geoffrey D., Jan, Nuzhat, Kahn, Jenna M., Kalman, Noah S., Mahon, Rebecca N., Weiss, Elisabeth, Zhao, Sherry S.   +6 more
core   +3 more sources